Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

0.0%

0 terminated/withdrawn out of 21 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

43%

9 trials in Phase 3/4

Results Transparency

55%

11 of 20 completed trials have results

Key Signals

11 with results

Enrollment Performance

Analytics

Phase 4

9(45.0%)

N/A

6(30.0%)

Phase 2

4(20.0%)

Phase 1

1(5.0%)

20Total

Phase 4(9)

N/A(6)

Phase 2(4)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (21)

Showing 20 of 21 trials

NCT06538285Phase 2Active Not Recruiting

Ketamine-Assisted Recovery for Methamphetamine Use Disorder & HIV

Role: collaborator

NCT04036396Not ApplicableCompleted

Mobile Enhanced Prevention Support for People Leaving Jail

Role: collaborator

NCT03681145Not ApplicableCompleted

Youth to Text or Telehealth for Engagement in HIV Care

Role: collaborator

NCT01957748Not ApplicableCompleted

CCTG 594: Engagement and Retention in Care for HIV+

Role: collaborator

NCT04295876Not ApplicableCompleted

The BRIDGES Project: Bridging Resources to Engage Women in Integrated HIV Care and Support Services

Role: collaborator

NCT02584140Phase 4Completed

Pre-exposure Prophylaxis (PrEP) Adherence Enhancement Guided by iTAB and Drug Levels for Women

Role: collaborator

NCT01941121Not ApplicableCompleted

CCTG 593: Testing and Linkage to Care

Role: collaborator

NCT04050371Phase 4Completed

Study of Truvada for HIV Pre Exposure Prophylaxis Using Daily Directly Observed Therapy to Look at Potential Interactions Between Truvada and Hormone Therapy

Role: collaborator

NCT03120936Phase 4Completed

The Stay Study: A Demonstration Project Advancing PrEP Delivery in the San Francisco Bay Area Transgender Community

Role: collaborator

NCT00925756Phase 4Completed

CCR5 Inhibitor Treatment Intensification on CD4+ T-cell Recovery

Role: collaborator

NCT00752856Phase 2Completed

Raltegravir + Lopinavir/Ritonavir Versus Efavirenz + Tenofovir + Emtricitabine in Treatment Naive Patients

Role: collaborator

NCT02367599Phase 4Completed

Effect of Vitamin D Supplementation on Bone Turnover Markers During PrEP in MSM

Role: collaborator

NCT01025427Phase 4Completed

HIV Persistence and Viral Reservoirs

Role: collaborator

NCT01761643Phase 4Completed

CCTG 595: Text Messaging Intervention to Improve Adherence to PrEP in High-risk MSM

Role: collaborator

NCT00845676Phase 4Completed

Treatment of Acute Hepatitis C Virus in HIV Co-Infection

Role: collaborator

NCT01198418Not ApplicableCompleted

A Web-based Intervention Study to Reduce High-risk Sexual Behavior by Persons Living With HIV AIDS (PLWH)

Role: collaborator

NCT01088295Phase 2Completed

HIV and Fat Accumulation

Role: collaborator

NCT00641888Completed

Impact of Antiretroviral Therapy on Cardiac Biomarkers

Role: collaborator

NCT01129401Phase 1Completed

Stonewall Treatment Evaluation Project

Role: collaborator

NCT01090102Phase 4Completed

Mesalamine to Reduce T Cell Activation in HIV Infection

Role: collaborator